Niklas Loman

1997–2024 年に発表

57
論文数
18,753
被引用数
47
h 指数
57
i10 指数

被引用数

Niklas Loman の年別被引用数1996 年: 被引用 2 件1997 年: 被引用 2 件1998 年: 被引用 9 件1999 年: 被引用 19 件2000 年: 被引用 14 件2001 年: 被引用 48 件2002 年: 被引用 93 件2003 年: 被引用 96 件2004 年: 被引用 121 件2005 年: 被引用 138 件2006 年: 被引用 106 件2007 年: 被引用 116 件2008 年: 被引用 94 件2009 年: 被引用 87 件2010 年: 被引用 136 件2011 年: 被引用 216 件2012 年: 被引用 203 件2013 年: 被引用 197 件2014 年: 被引用 206 件2015 年: 被引用 203 件2016 年: 被引用 248 件2017 年: 被引用 238 件2018 年: 被引用 216 件2019 年: 被引用 587 件2020 年: 被引用 671 件2021 年: 被引用 605 件2022 年: 被引用 434 件2023 年: 被引用 301 件2024 年: 被引用 493 件2025 年: 被引用 231 件2026 年: 被引用 9 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,290 件、この内訳の 24.3%イギリス: 引用元論文 735 件、この内訳の 7.8%中国: 引用元論文 711 件、この内訳の 7.6%イタリア: 引用元論文 447 件、この内訳の 4.7%カナダ: 引用元論文 422 件、この内訳の 4.5%ドイツ: 引用元論文 383 件、この内訳の 4.1%フランス: 引用元論文 347 件、この内訳の 3.7%オーストラリア: 引用元論文 319 件、この内訳の 3.4%スウェーデン: 引用元論文 305 件、この内訳の 3.2%スペイン: 引用元論文 297 件、この内訳の 3.2%オランダ: 引用元論文 248 件、この内訳の 2.6%日本: 引用元論文 190 件、この内訳の 2%
0%24.3%その他 28.9%

分野

  • Biochemistry, Genetics and Molecular Biology52.2%
  • Medicine40.8%
  • Immunology and Microbiology2.3%
  • Computer Science1.8%
  • Mathematics0.8%
  • Engineering0.3%
  • その他1.8%

トピック

  • BRCA gene mutations in cancer9.2%
  • PARP inhibition in cancer therapy8%
  • DNA Repair Mechanisms5.1%
  • Cancer Genomics and Diagnostics4.2%
  • Breast Cancer Treatment Studies4.2%
  • Ovarian cancer diagnosis and treatment3.5%
  • その他65.8%

共著者

全論文

検索で開く
  1. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sunil R. Lakhani, W Janni, Barbro Linderholm, T.-W. Liu, Niklas Loman, Larissa A. Korde, Sibylle Loibl, Peter C. Lucas, Frederik Marmé, E. Martinez de Dueñas, Robin McConnell, Kelly‐Anne Phillips, Martine Piccart, Giovanna Rossi, Rita K. Schmutzler, Elżbieta Senkus, Zhi-Ming Shao, Priyanka Sharma, Christian F. Singer, Tanja Španić, Elmar Stickeler, Masakazu Toi, Tiffany A. Traina, Giuseppe Viale, Gabriele Zoppoli, Y.H. Park, Rinat Yerushalmi, Huan Yang, D. Pang, Kyung Hae Jung, Audrey Mailliez, Zhaoqing Fan, Isabelle Tennevet, J. Zhang, T. Nagy, Gabe S. Sonke, Qiuhong Sun, Marina Parton, Marco Colleoni, Marcus Schmidt, Adam Brufsky, W. Razaq, Bella Kaufman, David Cameron, Christine Campbell, Andrew Tutt, P. Sevelda, Ferdinand Haslbauer, Monika Penzinger, Leopold Öhler, Christoph Tinchon, Richard Greil, Sonja Heibl, Rupert Bartsch, Viktor Wette, Christian F. Singer, Claudia Pasterk, Ruth Helfgott, Gunda Pristauz-Telsnigg, Herbert Stöger, A. Weltermann, Daniel Egle, I. Thiel, David Fuchs, Holger Rumpold, Kathrin Strasser‐Weippl, Beate Rautenberg, Volkmar Müller, Marcus Schmidt, Stefan Paepke ほか 509 名 - Annals of Oncology 2022 被引用: 447

  2. An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression

    著者: , , , , , , , , , , , , , , , - Cancer Cell 2017 被引用: 530

  3. Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fiona Lalloo, D. Gareth Evans, Douglas F. Easton - The American Journal of Human Genetics 2003 被引用: 3,685

  4. Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2014 被引用: 1,678

  5. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

    著者: , , , , , , , , , , , , , , - The Lancet 2010 被引用: 2,283

  6. Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study

    著者: , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2019 被引用: 317

  7. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

    著者: , , , , , , , , , , , , , , - The Lancet 2010 被引用: 1,636

  8. The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine

    著者: , , , , , , , , , , , , , , , , , , - Genome Medicine 2015 被引用: 285

  9. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - npj Breast Cancer 2022 被引用: 99

  10. Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kunle Odunsi, Simon A. Gayther, Susan M. Domchek, Banu Arun, Karen H. Lu, Gillian Mitchell, Beth Y. Karlan, Christine Walsh, Jenny Lester, Andrew K. Godwin, Harsh B. Pathak, Eric A. Ross, Mary B. Daly, Alice S. Whittemore, Esther M. John, Alexander Miron, Mary Beth Terry, Wendy K. Chung, David E. Goldgar, Saundra S. Buys, Ramūnas Janavičius, Laima Tihomirova, Nadine Tung, Cecilia M. Dorfling, Elizabeth J. van Rensburg, Linda Steele, Susan L. Neuhausen, Yuan Chun Ding, Bent Ejlertsen, Anne‐Marie Gerdes, Thomas van Overeem Hansen, Teresa Ramón y Cajal, Ana Osório, Javier Benı́tez, Javier Godino, María‐Isabel Tejada, M. Durán, Jeffrey N. Weitzel, Kristie Bobolis, Sharon Sand, Annette Campbell Fontaine, Antonella Savarese, Barbara Pasini, Bernard Peissel, Bernardo Bonanni, Daniela Zaffaroni, Francesca Vignolo-Lutati, Giulietta Scuvera, Giuseppe Giannini, Loris Bernard, Maurizio Genuardi, Paolo Radice, Riccardo Dolcetti, Siranoush Manoukian, Valeria Pensotti, Viviana Gismondi, Drakoulis Yannoukakos, Florentia Fostira, Judy E. Garber, Diana Torres, Muhammad Usman Rashid, Ute Hamann, Susan Peock, Debra Frost, Radka Platte, D. Gareth Evans, Rosalind A. Eeles, Rosemarie Davidson, Diana Eccles, Trevor Cole ほか 158 名 - JAMA 2015 被引用: 509

  11. Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative

    著者: , , , , , , , , , , , , , , , - JCO Precision Oncology 2018 被引用: 221

  12. Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Véronique Dièras, Bella Kaufman, Shani Paluch–Shimon, A. Wardley, A. Schneeweiss, Ana Filipa Ferreira, Max S. Mano, Haralabos P. Kalofonos, Claudia Andreetta, F. Puglisi, Filippo Montemurro, Sophie Barrett, Q. Zhang, Dimitriοs Mavroudis, Juan Antonio Matus, C. Villarreal Garza, C. Beato, Gustavo Ismael, Xiaoyu Hu, Hamdy Abdel Azeem, Rabab Gaafar, Christophe Perrin, Pierre Kerbrat, Johannes Ettl, Stefan Paepke, Erika Hitre, István Láng, Marc Trudeau, Sunil Verma, H. Li, Oliver Hoffmann, Bahriye Aktas, Anna Cariello, G. Cruciani, A. Tienghi, Carlo Tondini, T. Al-Twegieri, Niklas Loman, Robert Laing, David Miles, Étienne Brain, Peter A. Fasching, Michael P. Lux, Antonio Frassoldati, Zeba Aziz, J. Fernando Salas, Joanna Streb, K. Krzemieniecki, A Wroński, J. García García, Salomón Menjón Beltrán, I. Cicin, Peter Schmid, Chris Gallagher, Nicholas C. Turner, Zhongsheng Tong, Katalin Boér, Balázs Juhász, Zsolt Horváth, Giampaolo Bianchini, Luca Gianni, Giuseppe Curigliano, Alejandro Juárez Ramiro, Sneẑana Šušnjar, Eduarda Matos, Elena Sevillano, L. Garcia Estevez, Erhan Gökmen, Rüçhan Uslu, Hans Wildiers ほか 283 名 - Annals of Oncology 2021 被引用: 89

  13. Efficacy and safety of olaparib monotherapy in germline BRCA1 / 2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy

    著者: , , , , , , , , , , , , , , , - Gynecologic Oncology 2015 被引用: 300

  14. Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers

    著者: , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2020 被引用: 136

  15. Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial

    著者: , , , , , , , , - Breast Cancer Research 2018 被引用: 130

  16. Refinement of breast cancer molecular classification by miRNA expression profiles

    著者: , , , , , , , , , , , , , - BMC Genomics 2019 被引用: 104

  17. The mutational landscape of the SCAN‐B real‐world primary breast cancer transcriptome

    著者: , , , , , , , , , , , , , , - EMBO Molecular Medicine 2020 被引用: 69

  18. Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial

    著者: , , , , , , , , , , - Breast Cancer Research and Treatment 2013 被引用: 236

  19. Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE

    著者: , , , , , , , , , , , , , , , , , , - npj Breast Cancer 2022 被引用: 40

  20. Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xichun Hu, Rabab Gaafar, Hamdy Abdel Azeem, Christophe Perrin, Johannes Ettl, István Láng, Sunil Verma, Huiping Li, Étienne Brain, Oliver Hoffmann, Anna Cariello, Carlo Tondini, Taher Altwegeiri, Niklas Loman, Michael P. Lux, Antonio Frassoldati, Zeba Aziz, Fernando Palacios Salas, Joanna Streb, A Wroński, Salomón Menjón Beltrán, İrfan Çiçin, Peter Schmid, Robert Laing, Zhongsheng Tong, Katalin Boér, Balázs Juhász, Luca Gianni, Giuseppe Curigliano, Alejandro Juarez, Sneẑana Šušnjar, Erika Matos, Rüçhan Uslu, Hans Wildiers, Marcelo Cruz, Hugues Bourgeois, Raquel von Schumann, Salomon M. Stemmer, Flavia Morales Vásquez, Adriana Domínguez, Marek Z. Wojtukiewicz, Jasna Trifunović, José Juan Illarramendi, Laura García, Y. Izarzugaza Perón, María José Echarri, Natliia Voitko, Duncan Wheatley, Simon Waters, Richard de Boer, Guy Jérusalem, Véronique Cocquyt, Carlos H. Barrios, Lawrence Panasci, Johanna Mattson, Minna Tanner, M. Gozy, G. Vasilopoulos, János Révész, Luciano Latini, Cesare Gridelli, Jesus Miguel Lazaro, Antonio González, A. Barnadas Molins, Eduardo Martinez, Jesús Alarcón, Ana Arance, Leif Klint, Oleksiy Kovalyov, Richard D. Baird ほか 193 名 - Annals of Oncology 2019 被引用: 113

  21. Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort

    著者: , , , , , , , , , , , , - Clinical Cancer Research 2019 被引用: 55

  22. Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer

    著者: , , , , , , , , , , , , , , , , - Nature Communications 2024 被引用: 23

  23. Gene-Expression Profiles in Hereditary Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2001 被引用: 1,744

  24. Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic

    著者: , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2016 被引用: 150